IN THE NEWS

Community

Ritedose 2025 Year-In-Review 

Ritedose’s 2025 Year-In-Review highlights a year of growth, innovation, and purpose-driven impact, advancing patient access through expanded generics, operational excellence, and community investment.
READ MORE
Automated pharmaceutical warehouse with a yellow robotic arm stacking cardboard boxes, illustrating Ritedose’s focus on transparency, efficiency, and solutions for drug shortages.

Ritedose Pharmaceuticals Continues Tradition of Giving Back – Increases its Annual Donation to Unprecedented Amount of 1 Million Doses of Respiratory Medications to Dispensary of Hope for Low-income and Chronically lll Patients

COLUMBIA, S.C., August 12, 2024 – Ritedose Pharmaceuticals, a division of The Ritedose Corporation (Ritedose), the leading contract development and manufacturing organization (CDMO) specializing in sterile Blow Fill Seal (BFS) production, announces today that it will donate 1 Million (1M)…
READ MORE
FEATURED NEWS
RECEIVE THE LATEST NEWS

Get a healthy dose of all things Ritedose. Subscribe now for breaking news alerts, updates, previews, and more.

Please enter a valid email address.
TAGS CLOUD

Accessibility